TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 5, Pages 1260-1274
Publisher
Wiley
Online
2013-11-26
DOI
10.1111/bph.12530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TLR9-Dependent Activation of Dendritic Cells by DNA from Leishmania major Favors Th1 Cell Development and the Resolution of Lesions
- (2014) F. Hkima Abou Fakher et al. JOURNAL OF IMMUNOLOGY
- Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: Role of TLR4 and TLR9
- (2012) Asok Kumar Mukherjee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro
- (2012) S. Das et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Morphine activates neuroinflammation in a manner parallel to endotoxin
- (2012) X. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leishmania donovani Develops Resistance to Drug Combinations
- (2012) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20
- (2011) Sushmita Das et al. IMMUNOLOGY AND CELL BIOLOGY
- Toll-Like Receptors Participate in Macrophage Activation and Intracellular Control of Leishmania (Viannia) panamensis
- (2011) Carolina Gallego et al. INFECTION AND IMMUNITY
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Arabinosylated Lipoarabinomannan Skews Th2 Phenotype towards Th1 during Leishmania Infection by Chromatin Modification: Involvement of MAPK Signaling
- (2011) Parna Bhattacharya et al. PLoS One
- In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent
- (2010) K. Seifert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis
- (2010) V. S. Raman et al. JOURNAL OF IMMUNOLOGY
- The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma
- (2010) F. F. TUON et al. PARASITE IMMUNOLOGY
- Miltefosine Promotes IFN- -Dominated Anti-Leishmanial Immune Response
- (2009) P. Wadhone et al. JOURNAL OF IMMUNOLOGY
- Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines
- (2008) Q. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells
- (2007) Gabi Theiner et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More